Inventor
JOSHUA A. KAPLAN
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07DHeterocyclic compounds24%
C07BGeneral methods of organic chemistry9%
C07CAcyclic or carbocyclic compounds6%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
Y02EReduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution6%
PatentTitleYear
12,410,160KHK inhibitors202512,161,625Substituted pyrrolizine compounds and uses thereof202412,049,439Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives202411,980,609LPA receptor antagonists and uses thereof202411,939,318LPA receptor antagonists and uses thereof202411,584,738LPA receptor antagonists and uses thereof202311,225,473FXR (NR1H4) modulating compounds202211,136,290Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021Patents assigned to THE LIVER COMPANY INC (1)· patent assignee history
2021–2025Based in US· patent location history
2022–2025Patents assigned to GILEAD SCIENCES INC (6)· patent assignee history
2024Patents assigned to ORSOBIO INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GILEAD SCIENCES INC | 6 | 2022–2025 |
| ORSOBIO INC | 1 | 2024 |
| THE LIVER COMPANY INC | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2021–2025 |